Skip to Content

Journal of Composites Science, Volume 6, Issue 9

2022 September - 36 articles

Cover Story: Hemodialysis (HD) is a life-sustaining extracorporeal blood-purifying treatment for end-stage renal disease (ESRD) patients. However, this membrane-based therapy is associated with acute side effects, life-threatening chronic conditions, and unacceptably high morbidity and mortality rates. Heparin is a widely used anticoagulant substance that increases the clotting time and increases the membrane hemocompatibility. However, using heparin is challenging due to its severe or life-threatening side effects, such as heparin-induced thrombocytopenia (HIT), in addition to thrombosis (HITT). Therefore, the current study has thoroughly focused on different heparin HD membrane systems, the challenges of heparin-coated dialysis membranes, and the factors affecting its hemocompatibility, in addition to the methods that can be used to enhance its hemocompatibility. View this paper
  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles

There are no articles in this issue yet.
XFacebookLinkedIn
J. Compos. Sci. - ISSN 2504-477X